Drug Shortage Report for QUININE - ODAN
| Report ID | 88242 |
| Drug Identification Number | 00695459 |
| Brand name | QUININE - ODAN |
| Common or Proper name | Quinine Sulfate Tablets, USP |
| Company Name | ODAN LABORATORIES LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | QUININE SULFATE |
| Strength(s) | 300MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | P01BC |
| ATC description | ANTIMALARIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-07-02 |
| Estimated end date | 2019-09-20 |
| Actual end date | 2019-10-03 |
| Shortage status | Resolved |
| Updated date | 2019-10-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2019-10-22 | French | Compare |
| v4 | 2019-10-22 | English | Compare |
| v3 | 2019-07-03 | English | Compare |
| v2 | 2019-07-02 | French | Compare |
| v1 | 2019-07-02 | English | Compare |
Showing 1 to 5 of 5